Dr. Mohamad Bashar Abdelfattah, MD

Dr. Abdelfattah practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Abdelfattah's NPI, 1134539711, was assigned on May 5, 2014. Dr. Abdelfattah graduated from St. George's University School of Medicine in 2014. Dr. Abdelfattah's California license number on file is A167027.

Dr. Abdelfattah's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Abdelfattah also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Abdelfattah's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. Dr. Abdelfattah is also affiliated with Providence St. Jude Medical Center. The medical group on file is Newport Critical Care Physicians. Dmand AI also links Dr. Abdelfattah to 3 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelfattah practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Abdelfattah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Abdelfattah is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abdelfattah's licenses on file in 2 states: California and West Virginia.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), obesity and sleep apnea among the conditions Dr. Abdelfattah treats.

CMS data shows 103 Medicare services from Dr. Abdelfattah across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $9,458 for them.

CMS counts 82 Medicare patients who saw Dr. Abdelfattah in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelfattah's median patient age at 65, with 42% women.

In 2024, Dr. Abdelfattah wrote 612 Medicare Part D claims for 74 patients. 43% of them were for generic drugs. CMS names the drug for 511 of them, across 9 drugs with 11 or more claims each, at $113,740 in total drug cost. In 2023, CMS named 550 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Abdelfattah for performance year 2024, reported through an alternative payment model (APM). Dr. Abdelfattah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Abdelfattah in 2020. Dr. Abdelfattah's most frequent co-authors are Jonathan James Wanglun Chan, MD and Abhinav Mittal, MD.

CMS Open Payments shows 16 general payments to Dr. Abdelfattah from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $372.

Dr. Abdelfattah graduated from St. George's University School of Medicine in 2014.

Dr. Abdelfattah is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, LA Care and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.